Achillion Pharmaceuticals (ACHN) Misses Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts ACHN Hot Sheet
Price: $0.79 --0%
Financial Fact:
Loss from operations: -21.55M
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Loss from operations: -21.55M
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
Achillion Pharmaceuticals (NASDAQ: ACHN) reported Q2 EPS of ($0.25), $0.07 worse than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Achillion Pharmaceuticals (ACHN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Broadcom credit risk measures rise amid AI financing deals
- Morgan Stanley sees quality stocks and AI adopters leading market
- Bernstein SocGen on StandardAero Inc (SARO): ' Solid revenues, but short-term margin issues'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
